Baker Bros. Advisors as of Sept. 30, 2020
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 120 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seagen | 37.0 | $9.3B | 47M | 195.69 | |
BeiGene Sponsored Adr | 15.2 | $3.8B | 13M | 286.44 | |
Incyte Corporation (INCY) | 11.5 | $2.9B | 32M | 89.74 | |
ACADIA Pharmaceuticals (ACAD) | 6.9 | $1.7B | 42M | 41.25 | |
Alexion Pharmaceuticals | 4.0 | $1.0B | 8.8M | 114.43 | |
Kodiak Sciences (KOD) | 2.9 | $731M | 12M | 59.21 | |
BioMarin Pharmaceutical (BMRN) | 2.3 | $577M | 7.6M | 76.08 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 2.2 | $546M | 3.5M | 154.32 | |
Invitae (NVTAQ) | 2.1 | $514M | 12M | 43.35 | |
Myokardia | 1.6 | $410M | 3.0M | 136.33 | |
Prelude Therapeutics (PRLD) | 1.2 | $305M | 10M | 30.13 | |
argenx SE Sponsored Adr (ARGX) | 1.1 | $268M | 1.0M | 262.52 | |
Mirati Therapeutics | 0.9 | $234M | 1.4M | 166.05 | |
Igm Biosciences (IGMS) | 0.9 | $232M | 3.1M | 73.81 | |
EXACT Sciences Corporation (EXAS) | 0.8 | $188M | 1.8M | 101.95 | |
Madrigal Pharmaceuticals (MDGL) | 0.7 | $178M | 1.5M | 118.73 | |
Amarin Corporation Sponsored Adr (AMRN) | 0.5 | $135M | 32M | 4.21 | |
Heron Therapeutics (HRTX) | 0.4 | $89M | 6.0M | 14.82 | |
Forma Therapeutics Holdings SHS | 0.4 | $88M | 1.8M | 49.84 | |
Cerus Corporation (CERS) | 0.3 | $86M | 14M | 6.26 | |
Zymeworks | 0.3 | $80M | 1.7M | 46.58 | |
Insmed Incorporated Com Par $.01 (INSM) | 0.3 | $73M | 2.3M | 32.14 | |
Axsome Therapeutics (AXSM) | 0.3 | $68M | 960k | 71.25 | |
Neurocrine Biosciences (NBIX) | 0.3 | $65M | 677k | 96.16 | |
Kymera Therapeutics (KYMR) | 0.3 | $63M | 2.0M | 32.31 | |
Nurix Therapeutics (NRIX) | 0.2 | $63M | 1.8M | 34.91 | |
Allakos (ALLK) | 0.2 | $57M | 699k | 81.45 | |
ADC Therapeutics SA SHS (ADCT) | 0.2 | $56M | 1.7M | 32.99 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $54M | 2.5M | 21.67 | |
Horizon Therapeutics Public SHS | 0.2 | $52M | 667k | 77.68 | |
Global Blood Therapeutics In | 0.2 | $51M | 920k | 55.14 | |
Adaptimmune Therapeutics Sponsored Adr (ADAP) | 0.2 | $51M | 6.3M | 7.98 | |
Atreca Cl A Com (BCEL) | 0.2 | $49M | 3.5M | 13.97 | |
Chemocentryx | 0.2 | $49M | 900k | 54.80 | |
Neoleukin Therapeutics | 0.2 | $46M | 3.8M | 12.00 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $44M | 13M | 3.44 | |
Kiniksa Pharmaceuticals Com Cl A | 0.2 | $43M | 2.8M | 15.32 | |
Neurocrine Biosciences Note 2.25% 5/15/2024 (Principal) | 0.2 | $42M | 31M | 1.38 | |
Krystal Biotech (KRYS) | 0.1 | $33M | 775k | 43.05 | |
Pacific Biosciences of California (PACB) | 0.1 | $32M | 3.3M | 9.87 | |
Protagonist Therapeutics (PTGX) | 0.1 | $31M | 1.6M | 19.55 | |
Aeglea Biotherapeutics | 0.1 | $31M | 4.4M | 7.09 | |
Altimmune (ALT) | 0.1 | $29M | 2.2M | 13.20 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $27M | 897k | 30.17 | |
Assembly Biosciences | 0.1 | $25M | 1.5M | 16.44 | |
DBV Technologies Sponsored Adr | 0.1 | $25M | 15M | 1.73 | |
Merus N V (MRUS) | 0.1 | $25M | 2.0M | 12.00 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $24M | 1.6M | 14.73 | |
Cymabay Therapeutics | 0.1 | $24M | 3.3M | 7.24 | |
Alkermes SHS (ALKS) | 0.1 | $23M | 1.4M | 16.57 | |
Fulgent Genetics (FLGT) | 0.1 | $22M | 546k | 40.04 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $21M | 441k | 48.63 | |
Novavax (NVAX) | 0.1 | $20M | 187k | 108.35 | |
Immunomedics | 0.1 | $20M | 238k | 85.03 | |
Albireo Pharma | 0.1 | $18M | 549k | 33.37 | |
Frequency Therapeutics | 0.1 | $18M | 950k | 19.21 | |
Invitae Corporation Note 2.0% 9/1/2024 (Principal) | 0.1 | $17M | 10M | 1.64 | |
Athira Pharma (ATHA) | 0.1 | $16M | 882k | 18.46 | |
Xencor (XNCR) | 0.1 | $16M | 410k | 38.79 | |
BioMarin Pharmaceutical Note 0.599% 8/1/2024 (Principal) | 0.1 | $16M | 15M | 1.04 | |
Bluebird Bio (BLUE) | 0.1 | $14M | 252k | 53.95 | |
Harmony Biosciences Hldgs In (HRMY) | 0.1 | $14M | 400k | 33.90 | |
GW Pharmaceuticals Ads | 0.1 | $14M | 139k | 97.35 | |
Mirum Pharmaceuticals (MIRM) | 0.0 | $11M | 553k | 19.27 | |
Immatics SHS (IMTX) | 0.0 | $11M | 1.0M | 10.61 | |
Vaxart (VXRT) | 0.0 | $10M | 1.6M | 6.65 | |
Idera Pharmaceuticals Com Par | 0.0 | $9.9M | 4.6M | 2.14 | |
Urovant Sciences SHS | 0.0 | $9.1M | 979k | 9.34 | |
Sangamo Biosciences (SGMO) | 0.0 | $9.0M | 950k | 9.45 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $8.4M | 760k | 11.07 | |
Iveric Bio | 0.0 | $7.9M | 1.4M | 5.64 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $7.2M | 487k | 14.75 | |
uniQure SHS (QURE) | 0.0 | $7.2M | 194k | 36.83 | |
Cabaletta Bio (CABA) | 0.0 | $6.9M | 636k | 10.84 | |
Hookipa Pharma Inc equity | 0.0 | $6.6M | 701k | 9.47 | |
Syros Pharmaceuticals | 0.0 | $6.1M | 690k | 8.84 | |
Karuna Therapeutics Ord | 0.0 | $6.0M | 78k | 77.32 | |
Burning Rock Biotech Sponsored Ads | 0.0 | $6.0M | 237k | 25.08 | |
Autolus Therapeutics Sponsored Ads (AUTL) | 0.0 | $5.4M | 461k | 11.64 | |
Reata Pharmaceuticals Cl A | 0.0 | $5.2M | 53k | 97.42 | |
Replimune Group (REPL) | 0.0 | $4.8M | 207k | 23.02 | |
Crinetics Pharmaceuticals In (CRNX) | 0.0 | $4.7M | 302k | 15.67 | |
Inflarx Nv (IFRX) | 0.0 | $4.3M | 1.0M | 4.26 | |
Iteos Therapeutics (ITOS) | 0.0 | $4.1M | 168k | 24.67 | |
Akero Therapeutics (AKRO) | 0.0 | $4.1M | 132k | 30.79 | |
Legend Biotech Corporation Sponsored Ads (LEGN) | 0.0 | $4.0M | 128k | 30.87 | |
Denali Therapeutics (DNLI) | 0.0 | $3.6M | 99k | 35.84 | |
Passage Bio (PASG) | 0.0 | $3.4M | 261k | 13.11 | |
Ovid Therapeutics (OVID) | 0.0 | $3.4M | 591k | 5.74 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $3.4M | 200k | 16.83 | |
Chiasma | 0.0 | $3.2M | 742k | 4.30 | |
Inozyme Pharma (INZY) | 0.0 | $3.1M | 119k | 26.29 | |
Acceleron Pharma | 0.0 | $2.9M | 26k | 112.52 | |
Alector (ALEC) | 0.0 | $2.8M | 266k | 10.53 | |
Kezar Life Sciences | 0.0 | $2.8M | 575k | 4.84 | |
Constellation Pharmceticls I | 0.0 | $2.7M | 133k | 20.26 | |
Gamida Cell SHS | 0.0 | $2.6M | 633k | 4.15 | |
Tcr2 Therapeutics Inc cs | 0.0 | $2.5M | 123k | 20.32 | |
Intellia Therapeutics (NTLA) | 0.0 | $2.4M | 122k | 19.88 | |
Viking Therapeutics (VKTX) | 0.0 | $2.4M | 404k | 5.82 | |
Dicerna Pharmaceuticals | 0.0 | $2.0M | 113k | 17.99 | |
Arcus Biosciences Incorporated (RCUS) | 0.0 | $2.0M | 115k | 17.14 | |
Ngm Biopharmaceuticals | 0.0 | $1.9M | 118k | 15.91 | |
Galapagos NV Sponsored Adr (GLPG) | 0.0 | $1.8M | 12k | 141.88 | |
Bellicum Pharmaceuticals | 0.0 | $1.6M | 249k | 6.57 | |
Molecular Templates | 0.0 | $1.6M | 149k | 10.92 | |
Oyster Point Pharma | 0.0 | $1.4M | 68k | 21.11 | |
Orchard Therapeutics Ads | 0.0 | $1.4M | 343k | 4.11 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $1.4M | 474k | 2.97 | |
Genetron Holdings Ads | 0.0 | $1.2M | 100k | 11.94 | |
Leap Therapeutics | 0.0 | $1.1M | 560k | 1.98 | |
Evofem Biosciences | 0.0 | $1.0M | 433k | 2.36 | |
Applied Therapeutics (APLT) | 0.0 | $790k | 38k | 20.77 | |
Galmed Pharmaceuticals SHS | 0.0 | $725k | 205k | 3.53 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $679k | 580k | 1.17 | |
Adamas Pharmaceuticals | 0.0 | $675k | 164k | 4.12 | |
Affimed Therapeutics B V | 0.0 | $643k | 190k | 3.39 | |
Aravive | 0.0 | $357k | 76k | 4.71 | |
Genfit SA Ads (GNFT) | 0.0 | $150k | 28k | 5.28 | |
Sunesis Pharmaceuticals Com Par | 0.0 | $66k | 53k | 1.24 |